Loading company…
RevealDx develops clinical decision support software that guides follow-up and treatment for healthcare providers.
RevealDx offers a personalized diagnostic platform that gives clinicians evidence-based guidance on follow-up and treatment, aimed at reducing missed diagnoses and false positives. Customers include integrated delivery networks, accountable care organizations and clinics under risk-based contracts, mainly urban providers in the US, on subscription. Founded in 2014 by Samir Chowdhury in Seattle, US, it raised USD 3.63 mn in July 2024, which is also its total funding, and is listed at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in